Target intelligence / Profile preview

GATS protein-like 2 pseudogene (GATSL2 pseudogene)

Target
GATSL2 pseudogene
Molecular classification
Other (Pseudogene; not classified as receptor, enzyme, channel, transporter, or transcription factor)
01

Overview

The GATS protein-like 2 pseudogene (GATSL2 pseudogene; ENSG00000275121) is annotated as a pseudogene in the human genome, meaning it is a non-functional segment resembling a protein-coding gene but generally lacks the ability to produce a functional protein. It is not considered a therapeutic target, nor is it classified under typical target families like receptors, enzymes, or channels. No biological functions, disease associations, or drug interactions have been established for this pseudogene. The name GATS protein-like 2 pseudogene and related aliases (e.g., GATS-like protein 1, GATS-like protein 2, GATSL1) refer to non-functional or orphan gene entries and should not be confused with genuine drug targets or functional proteins. If you are seeking information on a functional or druggable target with a similar name (for example, GATS-like, GATSL, or CASTOR1/Cytosolic arginine sensor for mTORC1 subunit 1, which are bona fide proteins), please specify, as this entry does not correspond to a protein with established therapeutic relevance.

Other names
GATS-like protein 2GATS-like protein 1GATSL1
02

Biological functions

Other (No evidence of a direct protein-coding or regulatory biological function; as a pseudogene, canonical protein function is absent or unknown)
03

Disease associations

Other (No established direct role in disease)

Beyond the preview

Go deeper on GATS protein-like 2 pseudogene (GATSL2 pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GATS protein-like 2 pseudogene (GATSL2 pseudogene).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call